Copart (CPRT)
(Delayed Data from NSDQ)
$52.89 USD
+0.45 (0.85%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $53.22 +0.33 (0.62%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Price, Consensus and EPS Surprise
CPRT 52.89 +0.45(0.85%)
Will CPRT be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CPRT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CPRT
Copart, Inc. (CPRT) Rises As Market Takes a Dip: Key Facts
Copart, Inc. (CPRT) Beats Stock Market Upswing: What Investors Need to Know
CPRT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Copart, Inc. (CPRT) Registers a Bigger Fall Than the Market: Important Facts to Note
Is the Options Market Predicting a Spike in Copart (CPRT) Stock?
Why Is Copart (CPRT) Up 5.4% Since Last Earnings Report?
Other News for CPRT
Copart (CPRT) Shares Cross Above 200 DMA
NZS Capital Growth Equity Strategy Q3 2024 Investment Commentary
Conestoga Capital Advisors Q3 2024 Quarterly Commentary
Madison Mid Cap Fund Q3 2024 Investment Strategy Letter
Madison Investors Fund Q3 2024 Investment Strategy Letter